⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EBS News
Emergent Biosolutions, Inc.
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
globenewswire.com
EBS
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
globenewswire.com
EBS
Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
globenewswire.com
EBS
Pearl TV Launching Affordable NEXTGEN TV Converter Box Program to Support Consumer Transition to ATSC 3.0
businesswire.com
CMCSA
SBGI
T
CHTR
NXST
GNTX
EBS
TGNA
Dyna AI to Streamline Point-of-Care Decisions with Integrated Dosing and Medication Safety Information
prnewswire.com
EBS
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
globenewswire.com
EBS
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
globenewswire.com
EBS
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
globenewswire.com
EBS
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
globenewswire.com
EBS
Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness
globenewswire.com
EBS